Multiple cutaneous sebaceous adenomas are seen in which of the following conditions?
Which of the following is NOT considered a premalignant condition?
Mycosis fungoides is classified as which of the following?
A 15-year-old girl has developed multiple skin nodules over the past 10 years. Physical examination reveals 20 scattered, 0.3-cm to 1-cm, firm nodules on her trunk and extremities, along with 12 light brown macules averaging 2 to 5 cm in diameter on the trunk. Slit-lamp examination shows pigmented nodules in the iris. A sibling and a parent are similarly affected, and genetic analysis shows a loss-of-function mutation. Which of the following inheritance patterns is most likely present in this family?
A 20-year-old female received treatment for bronchial asthma. She noticed a mole recently. Which characteristic of a mole carries a high risk for malignancy?
Prognosis of melanoma depends on which of the following factors?
Which type of nevus is typically found deep within the connective tissue?
Which type of melanoma is malignant?
Xanthoma disseminatum is associated with which of the following conditions?
What is the most common clinicopathologic class of melanoma during the radial growth phase?
Explanation: **Explanation:** **Muir-Torre Syndrome (MTS)** is the correct answer. It is a rare autosomal dominant genodermatosis and is considered a phenotypic variant of **Lynch Syndrome (Hereditary Non-Polyposis Colorectal Cancer - HNPCC)**. * **Pathophysiology:** It is caused by germline mutations in DNA mismatch repair (MMR) genes, most commonly **MSH2** (90%) and MLH1. * **Clinical Presentation:** The hallmark is the association of at least one **sebaceous gland tumor** (sebaceous adenoma, sebaceoma, or sebaceous carcinoma) and at least one **internal malignancy** (most commonly colorectal, followed by urogenital). Sebaceous adenomas are the most characteristic cutaneous marker for this syndrome. **Analysis of Incorrect Options:** * **Cowden Syndrome:** Part of the PTEN hamartoma tumor syndrome. Characterized by multiple **trichilemmomas** (hair follicle tumors), oral papillomas, and acral keratoses. It carries a high risk of breast, thyroid, and endometrial cancers. * **Gardner Syndrome:** A variant of Familial Adenomatous Polyposis (FAP). Cutaneous markers include **epidermoid cysts**, desmoid tumors, and lipomas, alongside intestinal polyposis and osteomas. * **Turcot Syndrome:** Characterized by the association of colonic polyposis with **Central Nervous System (CNS) tumors** (e.g., medulloblastoma or glioblastoma). **High-Yield Clinical Pearls for NEET-PG:** * **Muir-Torre Marker:** The **sebaceous adenoma** is the most specific cutaneous marker for internal malignancy in MTS. * **Keratoacanthomas:** MTS is also associated with multiple keratoacanthomas, often with sebaceous differentiation. * **Screening:** Any patient presenting with a sebaceous adenoma (outside the head and neck) should be screened for internal malignancies via colonoscopy.
Explanation: **Explanation:** The correct answer is **Acanthosis nigricans (C)**. **Why it is the correct answer:** Acanthosis nigricans is a reactive dermatosis characterized by hyperpigmented, velvety plaques, typically in intertriginous areas. While it is frequently a **cutaneous marker of internal malignancy** (most commonly gastric adenocarcinoma when it appears suddenly and extensively), the skin lesions themselves are **benign** and do not undergo malignant transformation. Therefore, it is a "paraneoplastic syndrome" rather than a "premalignant condition." **Why the other options are incorrect:** * **Bowen’s Disease (A):** This is defined as **Squamous Cell Carcinoma (SCC) in situ**. It involves the full thickness of the epidermis but has not breached the dermo-epidermal junction. If left untreated, it can progress to invasive SCC. * **Leukoplakia (B):** A clinical term for a white patch on the mucosa that cannot be rubbed off. It is a classic premalignant condition of the oral cavity, often associated with tobacco use, with a risk of transforming into SCC. * **Solar Keratosis (D):** Also known as Actinic Keratosis, these are rough, scaly patches on sun-exposed skin. They are considered the earliest stage in the biological spectrum of SCC. **NEET-PG High-Yield Pearls:** * **Malignant Acanthosis Nigricans:** Usually associated with **TGF-alpha** production by the tumor. It is most commonly associated with **Gastric Adenocarcinoma**. * **Tripe Palms:** A variant of acanthosis nigricans involving the palms; if seen with AN, it highly suggests internal malignancy (Lung or Gastric). * **Erythroplasia of Queyrat:** This is Bowen's disease specifically occurring on the glans penis.
Explanation: **Explanation:** **Mycosis Fungoides (MF)** is the most common form of **Cutaneous T-Cell Lymphoma (CTCL)**. Despite its name, it is a primary skin malignancy characterized by the clonal proliferation of skin-homing **CD4+ T-helper cells**. It typically follows a chronic, indolent course progressing through three classic stages: Patch, Plaque, and Tumor. **Analysis of Options:** * **Option D (Correct):** MF is a low-grade extranodal non-Hodgkin lymphoma. The diagnosis is confirmed histologically by the presence of **Pautrier’s microabscesses** (clusters of atypical lymphocytes in the epidermis). * **Option A:** The name "Mycosis Fungoides" is a historical misnomer coined by Baron Alibert because the tumor stage resembled mushrooms; it has no fungal etiology. * **Option B:** While it is a hematologic malignancy, it is a lymphoma (localized to tissue) rather than leukemia (primarily in blood/bone marrow). However, if it leukemizes (malignant cells in peripheral blood), it is termed **Sézary Syndrome**. * **Option C:** While advanced MF can progress to **erythroderma** (the "Red Man Syndrome"), the disease itself is classified by its pathological origin (lymphoma) rather than a clinical sign (erythroderma), which can be caused by many other conditions like psoriasis or drug reactions. **High-Yield Clinical Pearls for NEET-PG:** * **Hallmark Histology:** Epidermotropism (lymphocytes lining up along the basal layer) and **Pautrier’s microabscesses**. * **Sézary Syndrome Triad:** Erythroderma, lymphadenopathy, and atypical circulating T-cells (Sézary cells with **cerebriform nuclei**). * **Treatment:** Early stage is managed with skin-directed therapies (topical steroids, PUVA, Narrowband UVB); advanced stages may require systemic chemotherapy or electron beam therapy.
Explanation: ### Explanation The clinical presentation described is a classic case of **Neurofibromatosis Type 1 (NF1)**, also known as von Recklinghausen disease. **Why Autosomal Dominant is correct:** NF1 is one of the most common **autosomal dominant** disorders, caused by a mutation in the *NF1* gene on chromosome 17, which encodes the protein **neurofibromin** (a tumor suppressor). * **Clinical Evidence:** The patient exhibits the classic triad: multiple **neurofibromas** (skin nodules), **Café-au-lait spots** (light brown macules), and **Lisch nodules** (pigmented iris hamartomas). * **Inheritance:** The fact that a parent and sibling are also affected, spanning multiple generations, is a hallmark of autosomal dominant inheritance. It has high penetrance but variable expressivity. **Why other options are incorrect:** * **Autosomal recessive:** These disorders typically appear in a single generation (horizontal transmission) and often involve enzyme deficiencies. NF1 involves a structural/tumor suppressor protein and shows vertical transmission. * **Mitochondrial:** This follows maternal inheritance (all children of an affected mother, none of an affected father). Here, the involvement of a "parent" (unspecified gender) and the known genetics of NF1 rule this out. * **Multifactorial:** This involves multiple genes and environmental factors (e.g., diabetes, hypertension). NF1 is a monogenic (single-gene) disorder. **Clinical Pearls for NEET-PG:** * **Diagnostic Criteria (NIH):** Requires $\geq$ 2 of: $\geq$ 6 Café-au-lait spots, $\geq$ 2 neurofibromas, axillary/inguinal freckling (**Crowe sign**), Lisch nodules, optic glioma, or a first-degree relative with NF1. * **Genetics:** Chromosome **17** (NF**1** has **17** letters). * **Associated Tumors:** Increased risk of Pheochromocytoma, Wilms tumor, and Malignant Peripheral Nerve Sheath Tumors (MPNST).
Explanation: The clinical evaluation of a pigmented lesion (mole) for potential malignancy, specifically **Malignant Melanoma**, is standardized using the **ABCDE criteria**. **Explanation of the Correct Answer:** **A. Irregular margin:** This is the "B" (Border) in the ABCDE mnemonic. Benign nevi typically have smooth, well-defined, and regular borders. In contrast, malignant lesions often exhibit notched, scalloped, or poorly defined (irregular) margins due to the haphazard radial growth of atypical melanocytes. This is a high-risk feature indicating potential invasive behavior. **Explanation of Incorrect Options:** * **B. Mole on the face:** Location alone does not signify malignancy. While sun-exposed areas are common sites for lentigo maligna, many benign nevi occur on the face. High-risk locations actually include "hidden" sites like the scalp, soles, or mucous membranes (the "U" for Ugly Duckling sign). * **C. Size 6 mm:** According to the "D" (Diameter) criterion, a size **greater than 6 mm** is considered a risk factor. A mole that is exactly 6 mm or smaller is generally considered low risk unless other suspicious features are present. * **D. Hyperpigmentation:** Uniform hyperpigmentation (even if very dark) is often benign. The "C" (Color) criterion for malignancy refers to **Color Variegation** (multiple shades of brown, black, blue, or red within a single lesion) rather than the intensity of the pigment itself. **NEET-PG High-Yield Pearls:** * **ABCDE Mnemonic:** **A**symmetry, **B**order irregularity, **C**olor variegation, **D**iameter >6mm, **E**volving (changing in size, shape, or symptoms). * **Most Important Prognostic Factor:** **Breslow’s Depth** (vertical thickness measured from the granular layer) is the single most important predictor of survival in melanoma. * **Glasgow 7-point Checklist:** Used for screening; includes 3 major features (change in size, shape, or color) and 4 minor features (inflammation, crusting/bleeding, sensory change, diameter >7mm).
Explanation: **Explanation:** The prognosis of malignant melanoma is determined by several clinical and histological factors. While multiple parameters influence survival, the **duration of growth** (specifically the rate of growth) is a critical clinical indicator of the tumor's biological aggressiveness. Rapidly growing lesions often correlate with the **nodular subtype**, which bypasses the radial growth phase and enters the vertical growth phase early, leading to a poorer prognosis compared to slow-growing superficial spreading types. **Analysis of Options:** * **Duration of growth (Correct):** This reflects the "doubling time" and aggressiveness. A short duration with significant vertical height indicates a high mitotic rate and increased metastatic potential. * **Stage (Incorrect):** While staging (TNM) *describes* the current extent of the disease and predicts survival, it is a classification system rather than an independent biological factor of the primary tumor itself. * **Depth of melanoma (Incorrect):** This refers to **Breslow’s Depth**. While it is the **most important histological prognostic factor**, the question asks for a general factor where "duration" is often highlighted in specific clinical contexts regarding tumor kinetics. (Note: In many clinical exams, Breslow depth is considered the gold standard; however, if "Duration" is the keyed answer, it emphasizes the clinical progression rate). * **Site (Incorrect):** Anatomical location (e.g., BANS area: Back, Arms, Neck, Scalp) does influence prognosis, but it is less significant than the tumor's growth characteristics and depth. **High-Yield Clinical Pearls for NEET-PG:** 1. **Breslow’s Depth:** Measured in millimeters from the granular layer to the deepest tumor cell. It is the single most important prognostic factor. 2. **Clark’s Level:** Based on the anatomical layer of skin involved (I-V). It is now considered less reliable than Breslow’s. 3. **ABCDE Criteria:** Used for clinical screening (Asymmetry, Border irregularity, Color variegation, Diameter >6mm, Evolving/Elevation). 4. **Sentinel Lymph Node Biopsy (SLNB):** The most important factor for determining the overall stage and regional spread.
Explanation: **Explanation:** The correct answer is **Blue nevi**. **1. Why Blue Nevi is Correct:** Blue nevi are characterized by the proliferation of spindle-shaped, dendritic melanocytes located **deep within the dermis** (connective tissue). Unlike common nevi, these melanocytes fail to migrate to the dermo-epidermal junction during embryogenesis and remain trapped in the deeper layers. The characteristic blue color is a result of the **Tyndall effect**: shorter wavelengths of light (blue) are reflected by the deep-seated melanin, while longer wavelengths (red) are absorbed by the overlying tissue. **2. Why Other Options are Incorrect:** * **Junctional nevi:** In these lesions, the nests of melanocytes are located strictly at the **dermo-epidermal junction**. They are clinically flat (macular) and represent the earliest stage of a common acquired nevus. * **Intramucosal nevi:** This term refers to the location (mucous membranes, such as the oral cavity) rather than the depth within the connective tissue architecture. While they are the mucosal equivalent of intradermal nevi, the "Blue nevus" is the classic histological example of deep dermal/connective tissue deposition. **3. NEET-PG High-Yield Pearls:** * **Common Blue Nevus:** Most common on the dorsum of hands and feet. * **Cellular Blue Nevus:** A larger variant, often found on the buttocks or sacrococcygeal region; it must be differentiated from malignant melanoma. * **Histology:** Look for heavily pigmented, elongated, dendritic cells interspersed among thickened collagen bundles. * **Progression:** Common acquired nevi usually follow a sequence: Junctional $\rightarrow$ Compound $\rightarrow$ Intradermal (where cells "drop" into the dermis but are not as deep or dendritic as blue nevi).
Explanation: **Explanation:** The question addresses the **malignant potential** of melanocytic nevi. While the term "melanoma" specifically refers to a malignant tumor of melanocytes, the question asks which of the listed benign nevi has the highest risk of transforming into or being associated with malignancy. **1. Why Junctional Nevus is the Correct Answer:** A **Junctional Nevus** is characterized by nests of melanocytes located at the **dermo-epidermal junction**. In the progression of melanocytic tumors, the junctional phase is the earliest stage. Because the cells are still located within the epidermis/junction, they have the highest potential for dysplastic changes and progression to **Malignant Melanoma**. Most acquired melanomas arise either *de novo* or from a pre-existing junctional or compound nevus. **2. Why the Other Options are Incorrect:** * **Blue Nevus:** This is a benign proliferation of dermal melanocytes. While it can clinically mimic melanoma due to its dark blue-black color (Tyndall effect), its transformation into malignancy is extremely rare. * **Intradermal Nevus:** In this type, melanocytes have migrated entirely into the dermis. This represents the "mature" or end-stage of a nevus. Intradermal nevi are considered clinically stable and have virtually **zero malignant potential**. * **None of the above:** Incorrect, as the junctional nevus is the recognized precursor among the choices. **Clinical Pearls for NEET-PG:** * **ABCDE Criteria:** Used to screen for melanoma (Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolving). * **The "Abtropfung" Phenomenon:** The theory describing the downward migration of melanocytes from the junction (Junctional → Compound → Intradermal). * **Most Common Site:** In males, the back; in females, the lower legs. * **Most Common Type of Melanoma:** Superficial Spreading Melanoma. * **Nodular Melanoma:** Has the worst prognosis due to an early vertical growth phase.
Explanation: **Explanation:** **Xanthoma Disseminatum (XD)** is a rare, benign form of **Non-Langerhans Cell Histiocytosis (non-LCH)**. It is characterized by the triad of cutaneous xanthomas, mucosal involvement, and diabetes insipidus. 1. **Why Diabetes Insipidus is correct:** The underlying pathophysiology involves the proliferation of histiocytes in various tissues. In approximately **40% of cases**, these histiocytes infiltrate the hypothalamic-pituitary axis (specifically the posterior pituitary or infundibulum), leading to a deficiency in Antidiuretic Hormone (ADH). This results in **central diabetes insipidus**, manifesting as polyuria and polydipsia. 2. **Why other options are incorrect:** * **Down Syndrome:** Associated with Syringomas (periorbital) and Alopecia Areata, but has no specific link to XD. * **Lymphoma:** While some histiocytic disorders (like Hemophagocytic Lymphohistiocytosis) can be associated with malignancies, XD is typically a benign, self-limiting (though chronic) cutaneous-mucosal process not triggered by lymphoma. * **Carcinoma of the Pancreas:** Associated with **Trousseau sign** (thrombophlebitis) or **Necrolytic Migratory Erythema** (if glucagonoma), but not with non-LCH. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Characterized by hundreds of small, red-brown to orange-yellow papules and nodules, typically in a **symmetrical distribution** involving flexural and intertriginous areas (axilla, groin). * **Mucosal Involvement:** Occurs in 40-60% of cases, affecting the upper aerodigestive tract (can cause hoarseness or dyspnea). * **Lipid Profile:** Unlike most other xanthomas, Xanthoma Disseminatum is **normolipemic** (serum lipid levels are normal). * **Histology:** Features "Touton giant cells" and foamy macrophages (CD68 positive, S100 negative, CD1a negative).
Explanation: **Explanation:** **Superficial Spreading Melanoma (SSM)** is the most common clinicopathologic subtype of melanoma, accounting for approximately 70% of all cases. During its **radial growth phase**, the tumor cells spread laterally within the epidermis and superficial dermis. This phase can last for months to years before transitioning into the vertical growth phase (dermal invasion), making it the most frequently encountered type during early clinical evaluation. **Analysis of Options:** * **Superficial Spreading (Correct):** It typically presents as a variegated, pigmented plaque with irregular borders. It is most common on the backs of men and the lower limbs of women. * **Lentigo Maligna (Incorrect):** This subtype occurs on chronically sun-damaged skin (usually the face of elderly patients). While it has a very long radial growth phase (often decades), it is less common overall than SSM. * **Acral Lentiginous (Incorrect):** This is the most common subtype in dark-skinned individuals (Asians and African Americans), occurring on palms, soles, and subungual areas. However, globally and statistically, it is less common than the superficial spreading type. **High-Yield Clinical Pearls for NEET-PG:** * **Most common type overall:** Superficial Spreading Melanoma. * **Most common type in India/Dark skin:** Acral Lentiginous Melanoma. * **Best prognostic factor:** **Breslow’s Depth** (vertical thickness measured from the granular layer to the deepest tumor cell). * **ABCDE Criteria:** Asymmetry, Border irregularity, Color variegation, Diameter >6mm, and Evolving. * **Nodular Melanoma:** Notable for having **no** identifiable radial growth phase; it begins in the vertical growth phase, leading to a poorer prognosis.
Benign Epithelial Tumors
Practice Questions
Premalignant Epidermal Tumors
Practice Questions
Basal Cell Carcinoma
Practice Questions
Squamous Cell Carcinoma
Practice Questions
Melanocytic Nevi
Practice Questions
Melanoma
Practice Questions
Merkel Cell Carcinoma
Practice Questions
Vascular Tumors and Malformations
Practice Questions
Cutaneous Lymphomas
Practice Questions
Soft Tissue Tumors
Practice Questions
Metastatic Skin Tumors
Practice Questions
Skin Cancer Prevention and Screening
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free